Article Information
History
- October 13, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Kailey Hughes1,*,
- Donald B Middleton1,2,
- Mary Patricia Nowalk2,
- Goundappa K Balasubramani2,
- Emily T Martin3,
- Manjusha Gaglani4,
- H Keipp Talbot5,
- Manish M Patel6,
- Jill M Ferdinands6,
- Richard K Zimmerman1,2,
- Fernanda P Silveira1,2,*,
- for the HAIVEN Study Investigators
- 1University of Pittsburgh Medical Center, Pittsburgh, PA
- 2University of Pittsburgh, Pittsburgh, PA
- 3University of Michigan School of Public Health, Ann Arbor, MI
- 4Baylor Scott & White Health, Texas A&M University College of Medicine, Temple, TX
- 5Vanderbilt University Medical Center, Nashville, TN
- 6Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA
- ↵*Corresponding author:
Fernanda P. Silveira, MD, MS, FIDSA, Associate Professor of Medicine, 3601 Fifth Avenue, Suite 5B, Pittsburgh, PA 15213, Phone: 412-648-6601, Fax: 412-648-6399, Email: silveirafd{at}upmc.edu, Alternate corresponding author:
Kailey Hughes, MPH, 3601 Fifth Avenue, Suite 5B, Pittsburgh, PA 15213, Phone: 412-648-6453, Fax: 412-648-6399, Email: hugheskl4{at}upmc.edu
Posted October 13, 2020.
Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults
